{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:54Z","timestamp":1791277914471,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.cbi.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T17:25:38Z","timestamp":1445275538000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells"],"prefix":"10.1016","volume":"242","author":[{"given":"Madhumita","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruma","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurba","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"e7889","DOI":"10.1371\/journal.pone.0007889","article-title":"Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death","volume":"4","author":"Robert","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2015.10.004_bib2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2015.10.004_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR\u2013ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2015.10.004_bib4","article-title":"Therapy of chronic myeloid leukemia: twilight of the imatinib era","volume":"2014","author":"Trela","year":"2014","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.cbi.2015.10.004_bib5","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1073\/pnas.210253497","article-title":"BCR\/ABL inhibition by an escort\/phosphatase fusion protein","volume":"97","author":"Lim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11899-012-0114-5","article-title":"Genetic mechanisms of chronic myeloid leukemia blastic transformation","volume":"7","author":"Skorski","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.cbi.2015.10.004_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00432-007-0280-3","article-title":"Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium","volume":"133","author":"Breitkreutz","year":"2007","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cbi.2015.10.004_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2147\/OTT.S64303","article-title":"Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development","volume":"7","author":"Mencalha","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.cbi.2015.10.004_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1189\/jlb.1104655","article-title":"Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK","volume":"78","author":"Hickey","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.cbi.2015.10.004_bib10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/10428190802007726","article-title":"Protein kinase C signalling in leukemia","volume":"49","author":"Redig","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.cbi.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cellsig.2010.10.013","article-title":"Regulation of protein kinase C function by phosphorylation on conserved and non-conserved sites","volume":"23","author":"Freeley","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cbi.2015.10.004_bib12","doi-asserted-by":"crossref","first-page":"16596","DOI":"10.1074\/jbc.M111.319756","article-title":"Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies","volume":"287","author":"Mitra","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2015.10.004_bib13","article-title":"Therapy of chronic myeloid leukemia: twilight of the imatinib era?","volume":"2014","author":"Trela","year":"2014","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.cbi.2015.10.004_bib14","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.leukres.2003.10.007","article-title":"Molecular mechanisms of resistance of leukemia to imatinibmesylate","volume":"28","author":"Tauchi","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cbi.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.leukres.2010.01.030","article-title":"Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs)","volume":"34","author":"Kalle","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cbi.2015.10.004_bib16","doi-asserted-by":"crossref","first-page":"13061","DOI":"10.1074\/jbc.M210015200","article-title":"Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein","volume":"278","author":"Corbit","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2015.10.004_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1258\/ebm.2012.011423","article-title":"Raf\/MEK\/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562","volume":"237","author":"Sancho","year":"2012","journal-title":"Exp. Biol. Med. Maywood"},{"key":"10.1016\/j.cbi.2015.10.004_bib19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1046\/j.1471-4159.2002.00896.x","article-title":"PKC and Raf-1 inhibition-related apoptotic signaling in N2a cells","volume":"81","author":"Bronisz","year":"2002","journal-title":"J.\u00a0Nerochem"},{"key":"10.1016\/j.cbi.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1242\/jcs.115.8.1575","article-title":"Extracellular signal regulated kinase (ERK)\/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases","volume":"115","author":"Hindley","year":"2002","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.cbi.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4236\/scd.2011.13006","article-title":"Bcr-Abl-mediated Raf kinase inhibitor protein suppression promotes chronic myeloid leukemia progenitor cells proliferation","volume":"1","author":"Nakamura","year":"2011","journal-title":"Stem Cell Discov."},{"key":"10.1016\/j.cbi.2015.10.004_bib22","first-page":"1905","article-title":"Role of nutrition in preventing cancer","volume":"53","author":"B\u00e9liveau","year":"2007","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.cbi.2015.10.004_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.21623","article-title":"Bioactive food components and cancer risk reduction","volume":"104","author":"Stan","year":"2008","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.cbi.2015.10.004_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/aps.2009.50","article-title":"Are isothiocyanates potential anti-cancer drugs?","volume":"30","author":"Wu","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2015.10.004_bib25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2014.2167","article-title":"Phenethyl isothiocyanate inhibits growth of human chronic myeloid leukemia K562 cells via reactive oxygen species generation and caspases","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/leu.2008.74","article-title":"Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"e21924","DOI":"10.1371\/journal.pone.0021924","article-title":"Exploiting mitochondrial dysfunction for effective elimination of Imatinib-resistant leukemic cells","volume":"6","author":"Kluza","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/01635581.2013.767366","article-title":"Targeting heat shock proteins (HSPs) by PEITC results in cell cycle arrest and apoptosis of human breast cancer cells","volume":"65","author":"Sarkar","year":"2013","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.cbi.2015.10.004_bib29","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","article-title":"Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol","volume":"22","author":"Puissant","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2015.10.004_bib30","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1038\/sj.onc.1206081","article-title":"Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML","volume":"21","author":"Druker","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2015.10.004_bib31","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells","volume":"62","author":"Yu","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2015.10.004_bib32","doi-asserted-by":"crossref","first-page":"e6124","DOI":"10.1371\/journal.pone.0006124","article-title":"ERK2, but not ERK1, mediates acquired and \u201cde novo\u201d resistance to imatinib mesylate: implication for CML therapy","volume":"4","author":"Aceves-Luquero","year":"2009","journal-title":"PLoS One"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:37:55Z","timestamp":1757857075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279715300831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"alternative-id":["S0009279715300831"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2015.10.004","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}